GERON CORP Operating Lease Liability
GERON CORP (GERN) had Operating Lease Liability of $5.43 million as of 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2021-08-16
- 2021-06-30: Operating Lease, Liability $5.43M.
- 2021-03-31: Operating Lease, Liability $5.55M.
- 2020-12-31: Operating Lease, Liability $5.68M.
- 2020-09-30: Operating Lease, Liability $5.79M.
| Period end | Operating Lease, Liability |
|---|---|
| 2021-06-30 | $5.43M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $5.55M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $5.68M 10-K · filed 2021-03-11 |
| 2020-09-30 | $5.79M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.85M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.99M 10-Q · filed 2020-05-28 |
| 2019-12-31 | $2.55M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |